Discrete choice experiments identifying attributes influencing treatment preference in mild asthma
C. Baggott (Wellington, New Zealand), J. Hardy (Wellington, New Zealand), H. Reddel (Sydney, Australia), J. Sparks (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), S. Mane (Wellington, New Zealand), M. Holliday (Wellington, New Zealand), R. Hancox (Dunedin, New Zealand), P. Hansen (Dunedin, New Zealand), R. Beasley (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand)
Source: International Congress 2019 – Inhalers: adherence and preference
Session: Inhalers: adherence and preference
Session type: Thematic Poster
Number: 4189
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Baggott (Wellington, New Zealand), J. Hardy (Wellington, New Zealand), H. Reddel (Sydney, Australia), J. Sparks (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), S. Mane (Wellington, New Zealand), M. Holliday (Wellington, New Zealand), R. Hancox (Dunedin, New Zealand), P. Hansen (Dunedin, New Zealand), R. Beasley (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand). Discrete choice experiments identifying attributes influencing treatment preference in mild asthma. 4189
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006
The influence of different schemes of basic treatment on functional indices in moderate–severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 54s Year: 2006
Physician‘s perception of pediatric asthma control is influenced by the use of medication Source: Eur Respir J 2003; 22: Suppl. 45, 365s Year: 2003
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 Year: 2021
A new perspective on concepts of asthma severity, control and optimum treatment Source: Eur Respir J 2009; 33: 704-705 Year: 2009
Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Nasal polyps as possible target to achieve the best biological treatment choice in severe asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma. Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018
Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management? Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine Year: 2014
Which clinical variables best predict asthma control? Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010
The consequences of different definitions in the prediction of asthma in children Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008
Population segmentation to identify priority targets for identification and behaviour change interventions in COPD Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011
Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Change in patients asthma control: Possible bias of transition ratings in clinical practice Source: Eur Respir J 2003; 22: Suppl. 45, 12s Year: 2003
Which traits to target in asthma? Importance of treatable traits varies depending on desired outcome Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
The factors influencing COPD self-care: a mixed methods study Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018
Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011
A pragmatic guide to choosing biologic therapies in severe asthma Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021 Year: 2021
Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project) Source: Eur Respir J 2002; 20: Suppl. 38, 329s Year: 2002